Pateclizumab

Pateclizumab
Monoclonal antibody
Type Whole antibody
Source Humanized (from mouse)
Target lymphotoxin alpha
Clinical data
Synonyms MLTA3698A
ATC code
  • none
Identifiers
CAS Number
ChemSpider
  • none
KEGG
Chemical and physical data
Formula C6436H9910N1710O2004S44
Molar mass 144.7 kDa
 ☒N☑Y (what is this?)  (verify)

Pateclizumab (MLTA3698A) is an immunomodulator. It binds to lymphotoxin alpha.[1][2]

This drug was developed by Genentech/Roche.

References

  1. ↑ World Health Organization (2011). "International Nonproprietary Names for Pharmaceutical Substances (INN). Proposed INN: List 105" (PDF). WHO Drug Information. 25 (2).
  2. ↑ Statement On A Nonproprietary Name Adopted By The USAN Council - Pateclizumab, American Medical Association.



This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.